Examination of TCGA-derived samples uncovered a notable increase in the proportion of CD4 memory-activated T cells, M1 macrophages, and M2 macrophages within the CLEC7A high-expression cohort of glioma patients (Figure 5B). Here, CD4 is linked to central nervous system cancer.